Evaluation of Docetaxel-Sensitive and Docetaxel-Resistant Proteomes in PC-3 Cells

Publisher： Karger

E-ISSN： 1423-0399|95|1|114-119

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.95, Iss.1, 2015-05, pp. : 114-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel in Patients with Anthracycline-Resistant Advanced Breast Cancer

By  

Oncology, Vol. 60, Iss. 1, 2000-12 ,pp. : 60-65

Karger

Access to resources Recommend Favorite

A Comparative Study of Protein Profiling by Proteomic Analysis in Camptothecin-Resistant PC3 and Camptothecin-Sensitive LNCaP Human Prostate Cancer Cells

By  

Urologia Internationalis, Vol. 77, Iss. 4, 2006-11 ,pp. : 347-354

Karger

Access to resources Recommend Favorite

Early Docetaxel and Androgen Deprivation in the Treatment of Metastatic, Hormone-sensitive Prostate Cancer

By  

Reviews on Recent Clinical Trials, Vol. 11, Iss. 4, 2016-10 ,pp. : 317-323

Bentham Science Publishers

Access to resources Recommend Favorite

Castrate-Resistant Prostate Cancer with Peritoneal Metastases Treated with Docetaxel-Based Chemotherapy

By  

Urologia Internationalis, Vol. 93, Iss. 1, 2013-11 ,pp. : 49-54

Karger

Access to resources Recommend Favorite

Optimal sequencing of docetaxel and abiraterone in men with metastatic castration‐resistant prostate cancer

By  

THE PROSTATE, Vol. 270-4137, Iss. 15, 2015-11 ,pp. : 1814-1820

John Wiley & Sons Inc

Access to resources Recommend Favorite